These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19925520)

  • 1. Analysis of SERPING1 and its association with age-related macular degeneration.
    Carter JG; Churchill AJ
    Acta Ophthalmol; 2011 Mar; 89(2):e212-3. PubMed ID: 19925520
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of a gene and environment risk model for age-related macular degeneration.
    Gibson J; Cree A; Collins A; Lotery A; Ennis S
    Br J Ophthalmol; 2010 Oct; 94(10):1382-7. PubMed ID: 20576771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.
    Ennis S; Jomary C; Mullins R; Cree A; Chen X; Macleod A; Jones S; Collins A; Stone E; Lotery A
    Lancet; 2008 Nov; 372(9652):1828-34. PubMed ID: 18842294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SERPING1 gene and age-related macular degeneration.
    Klaver CC; Bergen AA
    Lancet; 2008 Nov; 372(9652):1788-9. PubMed ID: 18842295
    [No Abstract]   [Full Text] [Related]  

  • 5. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
    Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
    Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF and age-related macular degeneration.
    McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
    Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
    [No Abstract]   [Full Text] [Related]  

  • 7. The SERPING1 gene and age-related macular degeneration.
    Allikmets R; Dean M; Hageman GS; Baird PN; Klaver CC; Bergen AA; Weber BH;
    Lancet; 2009 Sep; 374(9693):875-6; author reply 876-7. PubMed ID: 19748388
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration.
    Kurup SK; Gee C; Greven CM
    Acta Ophthalmol; 2010 Jun; 88(4):e145-6. PubMed ID: 19681792
    [No Abstract]   [Full Text] [Related]  

  • 9. SERPING1 rs2511988 and age-related macular degeneration.
    Kralovicova J; Vorechovsky I
    Lancet; 2009 Feb; 373(9662):461-2. PubMed ID: 19200915
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration.
    Immonen I; Seitsonen S; Tommila P; Kangas-Kontio T; Kakko S; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Ophthalmology; 2010 Jan; 117(1):103-8. PubMed ID: 19896188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorrect study design and analysis: the effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration.
    McGwin G
    Br J Ophthalmol; 2011 Nov; 95(11):1616; author reply 1616-7. PubMed ID: 21436175
    [No Abstract]   [Full Text] [Related]  

  • 12. Age-related macular degeneration: answers to some common questions.
    Smith SC; Lamb P; Liu J
    Insight; 2005; 30(3):17-21; quiz 22-3. PubMed ID: 16350357
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation in complement component C1 inhibitor in age-related macular degeneration.
    Gibson J; Hakobyan S; Cree AJ; Collins A; Harris CL; Ennis S; Morgan BP; Lotery AJ
    Immunobiology; 2012 Feb; 217(2):251-5. PubMed ID: 21852020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between SERPING1 rs2511989 polymorphism and age-related macular degeneration risk: a meta-analysis.
    Ma YB; Fu SY; Ma YH; Liu HL
    Mol Vis; 2014; 20():1434-42. PubMed ID: 25352749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related macular degeneration.
    El-Amir AN; Sagoo MS; da Cruz L
    Br J Hosp Med (Lond); 2005 Dec; 66(12):677-81. PubMed ID: 16417106
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration.
    Szaflik JP; Błasiak J; Krzyanowska A; Zaraś M; Janik-Papis K; Borucka AI; Woźniak K; Szaflik J
    Klin Oczna; 2009; 111(4-6):125-7. PubMed ID: 19673440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranibizumab for neovascular age-related macular degeneration.
    Liew G; Mitchell P
    N Engl J Med; 2007 Feb; 356(7):747-8; author reply 749-50. PubMed ID: 17301310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Identification of susceptibility genes for age-related macular degeneration--a success story of molecular genetics].
    Seitsonen S; Onkamo P; Immonen I; Järvelä I
    Duodecim; 2009; 125(21):2360-4. PubMed ID: 19999660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
    Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab.
    Barbazetto I; Saroj N; Shapiro H; Wong P; Freund KB
    Retina; 2010 Oct; 30(9):1376-85. PubMed ID: 20683380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.